RNA 3 0 -terminal phosphate cyclase (Rtc) is an enzyme involved in RNA splicing that converts the 3 0 -terminal hydroxyl group of truncated RNA to 2 0 ,3 0cyclic phosphate, which is required just before its ligation. This reaction may occur in the following two steps: (i) Rtc + ATP ! Rtc-AMP + PP i and (ii) RNA-N3 0 p + Rtc-AMP ! RNA-N>p + Rtc + AMP. In order to reveal the reaction mechanism, Rtc of Sulfolobus tokodaii (St-Rtc) overexpressed in Escherichia coli was purified and crystallized in the following states: St-Rtc, St-Rtc+Mn, St-Rtc+ATP, St-Rtc+AMP and St-Rtc-AMP. The crystals diffracted to 2.25-3.00 Å resolution and preliminary solutions of their structures have been obtained by molecular replacement using the structure of a selenomethioninelabelled St-Rtc crystal which was solved in advance using the MAD method as a model. These crystals grew in two different space groups (P3 1 and P4 2 ), with the former space group displaying two distinct packing modes.
Introduction
RNA 3 0 -terminal phosphate cyclase (Rtc) was initially identified in extracts of HeLa cells and Xenopus oocytes (Vicente & Filipowicz, 1988; Filipowicz & Shatkin, 1983) . This enzyme is localized in the nucleoplasm, which is consistent with its postulated role in RNA processing. This enzyme catalyzes the ATP-dependent conversion of a 3 0 -phosphate group to a 2 0 ,3 0 -terminal phosphodiester group at the 3 0 -end of various RNAs truncated by endonucleases. It has been proposed that the cyclization of the 3 0 -phosphate occurs in the following two steps:
ðiÞ Rtc þ ATP ! Rtc-AMP þ PP i ðiiÞ RNA-N3 0 p þ Rtc-AMP ! RNA-N>p þ Rtc þ AMP:
In step (i), Rtc and ATP react with each other to form a covalently bonded Rtc-AMP intermediate in the presence of Mg 2+ or Mn 2+ ion.
Step (ii) was proposed on detecting the formation of RNA-N 3 0 pp 5 0 A when the ribose at the RNA 3 0 -terminus was replaced by 2 0 -deoxyor 2 0 -O-methylribose (Filipowicz et al., 1985) . The cyclization step probably occurs non-enzymatically (Genschik & Filipowicz, 1998; Genschik et al., 1997; Palm et al., 2000) .
Rtc genes have been identified in eukaryotes, bacteria and archaea (Genschik et al., 1997) . The three-dimensional structure of Rtc of Escherichia coli has been determined by X-ray crystallography (Palm et al., 2000) . The structure is composed of two domains: large and small. The large domain consists of three repeats of the same folding module containing two -helices and a four-stranded -sheet. This motif of the module appears in several nucleic acid-binding proteins, for example the C-terminal domain of bacterial initiation factor 3 (IF3; Biou et al., 1995) . However, the catalytic mechanism and biological role of Rtc have not yet been clarified. The cellular RNA ligase identified in bacteria also requires 2 0 ,3 0 -cyclic ends for ligation (Greer et al., 1983; Arn & Abelson, 1996) . Therefore, it has been speculated that Rtc catalyzes the cyclization of the 3 0 -monophosphate-terminal group of truncated RNAs which are formed by decyclization with phosphodiesterase or by hydrolysis of the product of the above reactions, in order to regenerate the substrates in the subsequent ligation step.
In order to reveal the reaction mechanism of Rtc and its biological role by X-ray analyses, Rtc from Sulfolobus tokodaii (St-Rtc) and its selenomethione derivative (St-Rtc* 1 ) have been overexpressed in E. coli and crystallized in the following states: apo forms of St-Rtc and St-Rtc* to resolve the phase problem and to determine the free state of the enzyme as well as the effect of selenium substitution on the structure; a complex form with Mn 2+ ion (St-Rtc*+Mn) to identify the Mg 2+ ion-binding site; a complex with ATP but no Mg 2+ ion (St-Rtc*+ATP) to observe the ATP-bound state just before the first reaction; a complex with Mg 2+ and ATP under basic conditions (St-Rtc*-AMP) and a complex with Mg 2+ and ATP under acidic conditions (St-Rtc+AMP) 2 . The latter two structures will be of great interest in order to obtain insight into the effect of pH on the first reaction, since its optimal pH value has been reported to be 8-9 (Genschik et al., 1997; Palm et al., 2000) for the Rtcs from HeLa cells and E. coli.
Materials and methods

Overexpression and purification of St-Rtc and St-Rtc*
The gene encoding St-Rtc (gene ID ST0570, 339 amino acids, 37 505 Da, pI 9.89) was inserted into the pET-11a vector (Novagen). The recombinant plasmid was transformed in E. coli Rosetta-gami (DE3) (Novagen) and the cells were grown in LB culture at 310 K without induction. Following overnight incubation, the cells were harvested by centrifugation at 6000 rev min À1 for 10 min at 277 K and disrupted by sonication in 20 mM Tris-HCl pH 8.0 buffer. The cell lysates were incubated at 343 K for 30 min to denature the E. coli proteins.
After centrifugation at 18 000 rev min À1 for 20 min at 277 K, the supernatants were dialyzed against the same buffer containing 1.75 M ammonium sulfate and then applied onto a Resource ISO column (Amersham Bioscience). Bound proteins were eluted at a 2 ml min À1 flow rate with a linear gradient of 1.75-0 M ammonium sulfate in the same buffer. The pooled fractions were dialyzed against 50 mM MES (2-morpholinoethanesulfonic acid monohydrate titrated using NaOH) buffer pH 6.0 containing 5 mM -mercaptoethanol and loaded onto a Resource S column (Amersham Bioscience); the bound proteins were eluted at a 4 ml min À1 flow rate with a 0-0.4 M NaCl linear gradient in the same dialysis buffer.
After exchange of the buffer to 20 mM Tris-HCl pH 8.0 buffer containing 5 mM -mercaptoethanol and 150 mM NaCl, the pooled fractions were applied onto a HiLoad 16/60 Superdex 75 column (Amersham Bioscience) and the target proteins were eluted at a 1 ml min À1 flow rate. After buffer exchange to 10 mM potassium phosphate pH 7.0 containing 5 mM -mercaptoethanol, the pooled fractions were finally applied onto a BioScale CH51 column (Bio-Rad) and the proteins were eluted at a 2 ml min À1 flow rate using a linear 10-400 mM potassium phosphate concentration gradient at pH 7.0.
The proteins were concentrated to a final concentration of 5 mg ml À1 (A 280 = 1.56) in 20 mM Tris-HCl pH 8.0 using centrifugal filter devices (Vivaspin 500, Sartorius Stedim Biotech). The fractions obtained in all the purification steps as well as the concentrated proteins were analyzed by SDS-PAGE. pH values and UV absorption spectra were measured using F-13 (Horiba Ltd, Japan) and BioSpecmini (Shimadzu Corporation, Japan), respectively.
The selenomethionine derivative was expressed in E. coli B834 (DE3) (Novagen) using minimal M9 medium containing l-seleno- methionine. The same procedures and conditions as described above for the case of St-Rtc were used for the cultivation, isolation and purification of St-Rtc*. The only difference was the order of column chromatography after the Resource S column. The eluted fractions were first applied onto a BioScale CH51 column (Bio-Rad) and the bound proteins were eluted at a 2 ml min À1 flow rate with a 10-400 mM potassium phosphate pH 7.0 linear gradient containing 5 mM -mercaptoethanol. The eluted fractions were finally applied onto a HiLoad 16/60 Superdex 75 column (Amersham Bioscience) and the target proteins were eluted at a 1 ml min À1 flow rate using 20 mM Tris-HCl pH 8.0 buffer containing 5 mM -mercaptoethanol and 150 mM NaCl. The protein concentration was adjusted to 10 mg ml À1 in 20 mM Tris-HCl pH 8.0 using the same method as described above. The purity was analyzed by SDS-PAGE.
Crystallization
Crystallization trials were carried out using the hanging-drop vapour-diffusion method by mixing equal volumes (1 ml) of the protein and reservoir solutions and equilibrating the mixed solutions against 700 ml reservoir solution in a 24-well plate (Stem Corporation, Japan) at 293 K. Initial screening for potential crystallization conditions was performed with the Crystal Screen and Crystal Screen 2 kits (Hampton Research). The conditions under which crystalline precipitates appeared were further optimized by changing the concentrations of the protein, precipitant and salt and by changing the pH of the buffer. The prepared crystals were (1) the apo form of St-Rtc*, (2) the apo form of St-Rtc, (3) a complex with Mn 2+ ion (St-Rtc*+Mn), (4) a complex with ATP but not Mg 2+ under basic conditions (St-Rtc*+ATP), (5) a complex with ATP and Mg 2+ under basic conditions (St-Rtc*-AMP) and (6) a complex with ATP and Mg 2+ under acidic conditions (St-Rtc+AMP). In the cases of (5) and (6), the protein solution was incubated for 30 s to allow the first reaction. The droplets were then mixed with the reservoir solutions, basic or acidic, to maintain or change the pH of the droplet, respectively. For crys-tallizations, 24-well plates (Stem Corporation, Japan), plain glass cover slides (diameter 18 mm circle, Matsunami Glass Ind. Ltd, Japan) coated with silicon (L-25, Fuji Systems Corporation, Japan) and high-vacuum grease (Dow Corning Toray Co. Ltd, Japan) were used. The optimized crystallization conditions for the six types of crystals are given in Table 1 . based on X-ray absorption fine-structure (XAFS) measurement. The diffraction patterns at 100 K were recorded on an ADSC Quantum 4R CCD detector positioned at 210.8, 210.7, 209.3 and 215.0 mm away from the crystal for the four wavelengths, respectively; each frame was taken with a 10 s exposure time and with a 2 oscillation step over the full range of 360 . Bragg spots were indexed and their intensities were estimated by integrating around them. Intensity data were then merged and scaled between the frames with the HKL-2000 package (Otwinowski & Minor, 1997) . These data were further converted to structure-factor amplitudes using TRUNCATE from the CCP4 suite (Collaboration Computational Project, Number 4, 1994) . The remaining five crystals, St-Rtc, St-Rtc*+Mn, St-Rtc*+ATP, St-Rtc*-AMP and St-Rtc+AMP, were mounted on CryoLoops (Hampton Research) with 30-40% glycerol. Their diffraction patterns were taken in the oscillation range 0-180 on the BL-6A and NW-12 beamlines of Photon Factory and were processed using the methods described above.
X-ray data collection and preliminary structure analysis
The MAD method was used to solve the phase problem of the St-Rtc* crystal. The programs SHARP/autoSHARP (Vonrhein et al., 2007) , in combination with SHELXD (Sheldrick, 2008) , SOLOMON (Abrahams & Leslie, 1996) and ARP/wARP (Perrakis et al., 1999) , gave a unique plausible solution. The St-Rtc* structure was used as a probe in molecular replacement for the other crystals. The programs used were AMoRe (Navaza, 1994) and Phaser (McCoy et al., 2007) .
Results and discussion
After the final purification, the protein purity and molecular weights of the target proteins were estimated by SDS-PAGE (Fig. 1) . The target proteins appeared as main bands at positions corresponding to the molecular weights (St-Rtc, 37 505 Da; St-Rtc*, 37 786 Da) estimated from the amino-acid sequence. Thus, it was considered that the two proteins were highly purified for crystallization. Table 1 shows the conditions which produced crystals of St-Rtc*, St-Rtc and their complexes, while Fig. 2 shows images of the crystals and Fig. 3 shows examples of their diffraction patterns. The crystallographic data and statistics of the observed intensity data are given in Tables 2 and 3 . In every crystal, the acceptable Z value was always estimated to be 2; crystallization communications the V M values were in the range 2.44-2.99 Å 3 Da À1 and the solvent content was in the range 49.6-58.9%.
A preliminary crystal structure has been successfully solved by the MAD method and initial refinement yielded a correlation coefficient in |E 2 | of 0.822. This structure was then used to solve the remaining five crystal structures by molecular replacement. This confirmed the presence of a noncrystallographic dimer in each crystal form. Interestingly, the crystals grown under acidic conditions (St-Rtc, St-Rtc*+Mn and St-Rtc+AMP) belonged to space group P3 1 , while the crystals grown under basic conditions (St-Rtc*+ATP and St-Rtc*-AMP) belonged to space group P4 2 . This suggests that pH plays a significant role in selecting alternate molecular packings. Moreover, a closer examination of the P3 1 structures showed that their packing is not truly isomorphous: the protein molecules stacked along the 3 1 screw axis in the St-Rtc crystals are rotated by about 15 around the c axis compared with the other P3 1 crystal forms. Diagrams of the three crystal-packing arrangements are shown in Fig. 4 ; these also show that the proteins are reasonably packed with no molecular collisions. Full refinement and structure analysis is in progress and will be reported elsewhere. 
Figure 4
The molecular packing in the unit cells of the St-Rtc*, St-Rtc*+Mn and St-Rtc+AMP crystals (a), of the St-Rct crystal (b) and of the St-Rtc*-AMP and St-Rtc+AMP crystals (c). The two proteins forming a dimer are drawn with C chains in the same colour.
